Season one focusing on chronic disease management kicks off with a conversation with Stephanie Tilenius, CEO of Vida Health that aims to treat both the mind and the body.
Kharraz made a bold declaration about telehealth back in December 2020. In the final episode of 2022, we ask him about that and more.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However, will such efforts continue amidst the ongoing belt-tightening in a tough economy?
In this episode, we are conversing with Sonia Millsom, CEO of executive search firm Oxeon, to discuss trends shaping the marketplace following the Great Resignation as well as how Oxeon is spurring innovation through its venture studio.
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company's work in HIV and hepatitis and how her personal background informed her team's work in developing a Covid-19 treatment.
Digital health technologies have received plenty of attention, cash and sky-high valuations but do they deserve it? In the latest episode of MedCity's Pivot podcast, CEO of Hinge Health says companies need to validate their results in order to move the industry forward.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Renee Ryan hopes to see the vision of Cala Health's founder - who believed that Cala Health's wearable neurostimulation device can be one of the treatment modalities for chronic diseases like essential tremor - translated to reality.
Hurdle wants to address mental healthcare for minority populations whose problems are not well-addressed by the prevalent healthcare infrastructures. Learn about cultural humility (not cultural competency) and how that can address the depression and anxiety felt by so many. My own recent loss helps me understand the important work that Kevin and others are undertaking.
The Covid-19 pandemic has propelled virtual healthcare into our daily lives, although the quality of that experience varies. But one emerging trend from the scaling of telehealth is virtual-first care, as Wheel CEO and founder Michelle Davey explained.
In a wide-ranging discussion, Amwell Chairman & CEO Ido Schoenberg expressed frustration at being lumped together with other telehealth companies that have very different approaches and business models. But he was also very optimistic about the category overall.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Mike Alkire talked about the importance of health systems achieving scale such that they are in a better position vis-a-vis payers who are typically much larger.
In our conversation, Adrienne McFadden, who at one time was a practicing physician, speaks about the evolution of the company to more of a curated matchmaker connecting and guiding people to the best care available.
In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture - Zus Health - through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.
In this episode, I speak with John Martin, chief medical officer of Butterfly Network about how it is trying to transform the practice of medicine through a handheld ultrasound probe and data platform.
A conversation with Taha Kass-Hout reveals how machine learning can be leveraged to really harness data to improve outcomes and ultimately put people on a path to precision health.